Antibiotic Development Incentives Face Critical Test As NDA Reviews Begin
GAIN has encouraged FDA to be flexible on data requirements for antibiotics, according to sponsors.
GAIN has encouraged FDA to be flexible on data requirements for antibiotics, according to sponsors.